Abstract
Significant progress has been made to understand the immunopathogenesis of multiple sclerosis (MS) over recent years. Successful clinical trials with CD20-depleting monoclonal antibodies have corroborated the fundamental role of B cells in the pathogenesis of MS and reinforced the notion that cells of the B cell lineage are an attractive treatment target. Therapeutic inhibition of Bruton's tyrosine kinase (BTK), an enzyme involved in B cell and myeloid cell activation and function, is regarded as a next-generation approach that aims to attenuate both errant innate and adaptive immune functions. Moreover, brain-penetrant BTK inhibitors may impact compartmentalized inflammation and neurodegeneration within the central nervous system by targeting brain-resident B cells and microglia, respectively. Preclinical studies in animal models of MS corroborated an impact of BTK inhibition on meningeal inflammation and cortical demyelination. Notably, BTK inhibition attenuated the antigen-presenting capacity of B cells and the generation of encephalitogenic T cells. Evobrutinib, a selective oral BTK inhibitor, has been tested recently in a phase 2 study of patients with relapsing-remitting MS. The study met the primary endpoint of a significantly reduced cumulative number of Gadolinium-enhancing lesions under treatment with evobrutinib compared to placebo treatment. Thus, the results of ongoing phase 2 and 3 studies with evobrutinib, fenobrutinib, and tolebrutinib in relapsing-remitting and progressive MS are eagerly awaited. This review article introduces the physiological role of BTK, summarizes the pre-clinical and trial evidence, and addresses the potential beneficial effects of BTK inhibition in MS.
Keywords: Multiple sclerosis, immunopathogenesis, B cell, Bruton's tyrosine kinase, disease-modifying therapy, immunomodulation, demyelination.
[http://dx.doi.org/10.1097/WCO.0000000000000685] [PMID: 30893100]
[http://dx.doi.org/10.1016/B978-0-444-52001-2.00001-7] [PMID: 24507511]
[http://dx.doi.org/10.1016/j.autrev.2011.02.006] [PMID: 21354338]
[http://dx.doi.org/10.1002/ana.25927] [PMID: 33091175]
[http://dx.doi.org/10.1016/j.autrev.2020.102647] [PMID: 32801039]
[http://dx.doi.org/10.3390/ijms18102048] [PMID: 28946620]
[http://dx.doi.org/10.3389/fimmu.2019.00201] [PMID: 30800132]
[PMID: 33248250]
[PMID: 15944945]
[http://dx.doi.org/10.1080/14728214.2020.1724282] [PMID: 31996046]
[http://dx.doi.org/10.1016/j.hoc.2020.06.007] [PMID: 32861286]
[PMID: 32810857]
[http://dx.doi.org/10.1080/14728214.2019.1647165] [PMID: 31327278]
[http://dx.doi.org/10.1038/nchembio.481] [PMID: 21113169]
[http://dx.doi.org/10.1007/s00401-020-02204-z] [PMID: 32761407]
[http://dx.doi.org/10.1093/brain/awab045] [PMID: 33724342]
[http://dx.doi.org/10.1002/eji.1830231210] [PMID: 8258324]
[http://dx.doi.org/10.1038/s41423-019-0270-9] [PMID: 31431692]
[PMID: 8283037]
[http://dx.doi.org/10.1111/j.0105-2896.2005.00225.x] [PMID: 15661031]
[http://dx.doi.org/10.1016/0092-8674(93)90667-F] [PMID: 8425221]
[http://dx.doi.org/10.1038/361226a0] [PMID: 8380905]
[PMID: 2391416]
[PMID: 10887125]
[http://dx.doi.org/10.1200/JCO.2013.53.1046] [PMID: 24778403]
[http://dx.doi.org/10.1002/eji.201040521] [PMID: 20623551]
[http://dx.doi.org/10.4049/jimmunol.0900367] [PMID: 19841184]
[http://dx.doi.org/10.1016/j.molimm.2004.04.008] [PMID: 15219998]
[http://dx.doi.org/10.1126/science.271.5250.822] [PMID: 8629002]
[http://dx.doi.org/10.1084/jem.191.10.1745] [PMID: 10811867]
[http://dx.doi.org/10.1084/jem.184.1.31] [PMID: 8691147]
[http://dx.doi.org/10.1046/j.1365-2249.1997.4581478.x] [PMID: 9409640]
[http://dx.doi.org/10.1615/CritRevImmunol.2018025184] [PMID: 29717662]
[http://dx.doi.org/10.3389/fimmu.2017.01454] [PMID: 29167667]
[http://dx.doi.org/10.1074/jbc.M301484200] [PMID: 12724322]
[http://dx.doi.org/10.1371/journal.pone.0074103] [PMID: 23967355]
[http://dx.doi.org/10.1038/ncomms8360] [PMID: 26059659]
[PMID: 10438910]
[http://dx.doi.org/10.1371/journal.pone.0085834] [PMID: 24465735]
[http://dx.doi.org/10.1016/j.cell.2019.08.053] [PMID: 31585077]
[http://dx.doi.org/10.3389/fncel.2018.00329] [PMID: 30333729]
[http://dx.doi.org/10.4049/jimmunol.171.4.1850] [PMID: 12902486]
[http://dx.doi.org/10.1007/s11481-019-09839-0] [PMID: 30758770]
[http://dx.doi.org/10.3233/BPL-200100] [PMID: 33282676]
[http://dx.doi.org/10.1371/journal.pone.0137641] [PMID: 26348529]
[http://dx.doi.org/10.1172/JCI75328] [PMID: 25271622]
[http://dx.doi.org/10.1038/nrc.2017.121] [PMID: 29348577]
[PMID: 33122850]
[http://dx.doi.org/10.3389/fcell.2021.630942] [PMID: 33777941]
[http://dx.doi.org/10.3389/fonc.2020.591577] [PMID: 33154951]
[http://dx.doi.org/10.1002/onco.13685]
[http://dx.doi.org/10.1007/978-3-319-91439-8_14] [PMID: 30069636]
[http://dx.doi.org/10.1182/bloodadvances.2018030007] [PMID: 31088809]
[http://dx.doi.org/10.1182/blood.2020006844] [PMID: 32731259]
[http://dx.doi.org/10.1038/s41375-021-01123-6] [PMID: 33526860]
[http://dx.doi.org/10.1182/hematology.2020000118] [PMID: 33275698]
[http://dx.doi.org/10.1007/s11899-020-00576-3] [PMID: 32415406]
[http://dx.doi.org/10.1021/acs.jmedchem.9b00794] [PMID: 31368705]
[http://dx.doi.org/10.1186/s12974-018-1308-0] [PMID: 30231870]
[http://dx.doi.org/10.1182/blood-2004-01-0207] [PMID: 15117762]
[http://dx.doi.org/10.1002/1521-4141(200207)32:7<1939::AID-IMMU1939>3.0.CO;2-S] [PMID: 12115614]
[http://dx.doi.org/10.1056/NEJMoa1901981] [PMID: 31075187]
[http://dx.doi.org/10.1038/s41591-020-0833-4] [PMID: 32313250]
[http://dx.doi.org/10.1016/j.ejmech.2021.113329] [PMID: 33740548]
[http://dx.doi.org/10.1186/1471-2377-12-36] [PMID: 22691628]
[http://dx.doi.org/10.3389/fimmu.2018.03116] [PMID: 30687321]
[http://dx.doi.org/10.1016/j.drudis.2019.05.009] [PMID: 31100209]
[http://dx.doi.org/10.3390/vaccines9020099] [PMID: 33525459]
[PMID: 33340215]
[http://dx.doi.org/10.1016/j.jmb.2013.11.024] [PMID: 24316048]
[http://dx.doi.org/10.2147/JIR.S277716] [PMID: 33531826]
[http://dx.doi.org/10.1126/sciimmunol.abd0110] [PMID: 32503877]
[PMID: 33328281]
[http://dx.doi.org/10.3389/fimmu.2019.01883] [PMID: 31440255]
[http://dx.doi.org/10.1111/ene.14713] [PMID: 33386655]
[http://dx.doi.org/10.1007/s00415-020-10107-y] [PMID: 32719975]
![Wayfinder Image](/images/wayfinder.jpg)